載入...
α-Galactosidase A Augmentation by Non-Viral Gene Therapy: Evaluation in Fabry Disease Mice
Fabry disease (FD) is a monogenic X-linked lysosomal storage disorder caused by a deficiency in the lysosomal enzyme α-Galactosidase A (α-Gal A). It is a good candidate to be treated with gene therapy, in which moderately low levels of enzyme activity should be sufficient for clinical efficacy. In t...
Na minha lista:
| 發表在: | Pharmaceutics |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8224287/ https://ncbi.nlm.nih.gov/pubmed/34064206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13060771 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|